玖、參考文獻
張恬嘉,2015。幾丁聚醣與魚油改善高脂飲食引起的大鼠肥胖及脂肪肝之研究。國立台灣海洋大學食品科學系碩士論文。張淑美,1994。魚油對 streptozotocin 所引起的糖尿病大白鼠肥胖脂質代謝與糖代謝之影響。國立台灣海洋大學食品科學系碩士論文。Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans, RM. PPAR γ signaling and metabolism: the good, the bad and the future. Nat. Med. 2013; 99: 557 – 566.
Albertsson CE. The role of uncoupling proteins in the regulation of metabolism. Acta. Physiol. Scand. 2003; 178: 405 – 412.
Aoyama T, Peters JM, Iritanii N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. Altered constitutive expression of fatty acid - metabolizing enzymes in mice lacking the peroxisome proliferator - activated receptor α (PPARα). J. Biol. Chem. 1998; 273: 5678 –5684.
Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med. 1995; 27: 435 – 438.
Azain MJ. Role of fatty acids in adipocyte growth and development. J. Anim. Sci. 2004; 82: 916 – 924.
Baillie RA, Takada R, Nakamura M, Clarke SD. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. PLEFA 1999; 60: 351 – 356.
Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators. Inflamm. 2010; 2010; 1 – 19.
Baumgartner RN. Body composition in healthy aging. Ann. N. Y. Acad. Sci. 2000; 904: 437 – 448.
Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1 – 28.
Berard AM, Dumon MF, Darmon M. Dietary fish oil up-regulates cholesterol 7α-hydroxylase mRNA in mouseliver leading to an increase in bile acid and cholesterol excretion. FEBS Letters 2004; 559: 125 – 128.
Berger JJ and Barnard RJ. Effect of diet on fat cell size and hormone-sensitive lipase activity. J. Appl. Physiol. 1999; 87: 227 – 232.
Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Obesity, peroxisome proliferator - activated receptor, and atherosclerosis in type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 28 - 40.
Boss O, Hagen T, Lowell BB. Uncoupling proteins 2 and 3 potential regulators of mitochondrial energy metabolism. Diabetes 2000; 49: 143 – 156.
Botham KM, Zheng X, Napolitano M, Avella M, Cavallari C, Rivabene R, Bravo E. The effects of dietary n-3 polyunsaturated fatty acids delivered in chylomicron remnants on the transcription of genes regulating synthesis and secretion of very-low-density lipoprotein by the liver: modulation by cellular oxidative state show all authors. Exp. Biol. Med. 2003; 228: 143 – 151.
Brand MD and Esteves TC. Physiological functions of the mitochondrial uncoupling proteins UCP 2 and UCP 3. Cell Metab. 2005; 2: 85 – 93.
Brown RJ, Lagor WR, Sankaranaravanan S, et al. Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ. Res. 2010; 107: 357 - 364.
Budohoski L, Kresowska PB, Langfort J. Effects of saturated and polyunsaturated fat enriched diet on the skeletal muscle insulin sensitivity in young rats. J. Physiol. Pharmacol. 1993; 44: 391 – 398.
Calder PC. n - 3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006; 83: 1505 - 1519.
Carling D. The AMP-activated protein kinase cascade – a unifying system for energy control. Trends. Biochem. Sci. 2004; 29: 18 – 24.
Carlson SE and Goldfarb S. A sensitive enzymatic method for the determination of free and esterified tissue cholesterol. Clinica. Chimica. Acta, 1977; 79: 575 - 582.
Carmen GY and Vı´ctor SM. Signalling mechanisms regulating lipolysis. Cell. Signal. 2006; 18: 401 – 408.
Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M. Sarcopenia, obesity, and inflammation—results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am. J. Clin. Nutr. 2005; 82: 428 – 434.
Chan DC, Chen MM, Ooi EM, Watts GF. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Int. J. Clin. Pract. 2008; 62: 799 - 809.
Chancharme L, Thérond P, Nigon F, Zarev S, Mallet A, Bruckert E, Chapman MJ. LDL particle subclasses in hypercholesterolemia: molecular determinants of reduced lipid hydroperoxide stability. J. Lipid Res. 2002; 43: 453 - 462.
Chang XX, Yan HM, Fei J, Jiang MH, Zhu HG, Lu DR and Gao X. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. J. Lipid Res. 2010; 51:2504 – 2515.
Chen YDI, Risser TR, Cully M, Reaven GM. Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity? Diabetes 1979; 28: 893 – 898.
Cromwell WC and Otvos.JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr. Atheroscler. Rep. 2004; 6: 381 – 387.
Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME. Peroxisome proliferator activator receptor gamma coactivator - 1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen - activated protein kinase activation. J. Biol. Chem. 2007; 282: 15439 – 15450.
Cruz WS, Kwon G, Marshall CA, McDaniel ML, Semenkovich CF. Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells a potential link between insulin resistance and β-cell dysfunction. J. Biol. Chem. 2001; 276: 12162 - 12168.
Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 1998; 273: 30057 - 30060.
Desvergne B and Wahli W. Peroxisome proliferator-activated receptor : nuclear control of metabolism. Endocr. Rev. 1999; 20: 649 - 688.
Duval C, Müller M, Kersten, S. PPARα and dyslipidemia. Biochim. Biophys. Acta. 2007; 1771: 913 - 1112.
Enerback S. The origins of brown adipose tissue. N. Engl. J. med. 2009; 360: 2021 – 2023.
Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli, W., Desvergne, B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001; 142: 4195 – 4202.
Esterbauer H, Oberkofler H, Krempler F. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPAR - GC1) gene : cDNA sequence , genomic organization , chromosomal localization , and tissue expression. Genomics. 1999; 62: 98 – 102.
Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. HEPATOLOGY 2009; 51: 679 – 689.
Fazio S and Yao Z. The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 593-600.
Ferreira LD, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein Lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 2001; 50: 1064 – 1068.
Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 2001; 276: 27855 – 27863.
Fisher RM, Coppack SW, Humphreys SM, Gibbons GF, Frayn KN. Human triacylglycerol - rich lipoprotein subfractions as substrates for lipoprotein lipase. Clinica. Chimica. Acta. 1995; 236: 7 – 17.
Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J. boil. Chem. 1957; 497 – 509.
Fonseca-Alaniz MH; Takada J; Cardoso Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J. Pediatr. (Rio J.) 2007; 83 (suppl):.
Fungwe TV, Cagen L, Wdcox HG, Heimberg M. Regulation of hepatic secretion of very low density lipoprotein by dietary cholesterol. J. Lipid Res. 1992; 33: 179 - 191.
Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML. Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 2003; 278: 34268 - 34276.
Ginsberg HN and Fisher EA. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. J. Lipid. Res. 2009; 50: 162 – 166.
Gleeson A, Anderton K, Owens D, Bennett A, Collins P, Johnson A, White D, Tom GH. The Role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 1999; 42: 944 – 948.
Gordon DA.. Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein assembly. Curr. Opin. Lipidol. 1997; 8: 131 – 137.
Gotoh N, Nagao K, Onoda S, Shirouchi B, Furuya K. Effects of three different highly purified n-3 series highly unsaturated fatty acids on lipid metabolism in C57BL/KsJ-db/db mice. J. Agric. Food Chem. 2009; 57: 11047 - 11054.
Griffin BA, and Zampelas A. Influence of dietary fatty acids on the atherogenic lipoprotein phenotype. Nutr. Res. Rev. 1995; 8: 1 – 26.
Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36 - null mice. J. Clin. Invest. 2002; 109: 1381 – 1389.
Hansen PA, Han DH, Marshall BA. A high fat diet impairs stimulation of glucose transport in muscle : functional evaluation of potential mechanisms. J. Biol. Chem. 1998; 273: 26157 – 26163.
Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003; 546: 113 – 120.
Hardie DG. The AMP-activated protein kinase pathway – new players upstream and downstream. J. Cell Sci. 2004; 117: 5479 - 5487.
Henderson B, Pettipher ER, Higgs GA. Mediators of rheumatoid arthritis. Br. Med. Bull. 1987; 43: 415 – 428.
Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific PPAR - γ deletion causes insulin resistance. Nat. Med. 2003; 9: 1491 – 1497.
Hoffler U, Hobbie K, Wilson R, Bai R, Rahman A, Malarkey D, Travlos G, Ghanayem BI. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine 2009; 36: 311 – 325.
Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem. Soc. Trans. 2003; 31: 1120 - 1124.
Houten SM and Auwerx J. PGC - 1α: Turbocharging mitochondria. Cell 2004; 119: 5 – 7.
Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von Eckardstein A, Assmann G, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 1998; 273: 26388 - 26393.
Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, Schindler K, Bohdjalian A, Mascher D, Vangala S, Schranz M, Krebs M, Bischof MG, Stulnig TM. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial1–3. Am. J. Clin. Nutr. 2012; 96: 1137 – 1149.
James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000; 71 (suppl): 343 – 348.
Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, Kus V, Hensler M, Janovska P, Miksik I, Baranowski M, Gorski J, Hebrard S, Jensen TE, Flachs P, Hawley S, Viollet B, Kopecky J. AMP-activated protein kinase alpha 2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes 2010; 59: 2737 – 2746.
Jensen DR, Schlaepfer IR, Morin CL, Pennington DS, Marcell T, Ammon SM, Gutierrez-Hartmann A, Eckel RH. Prevention of dietinduced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1997; 273: 683 - 689.
Ježek P. Possible physiological roles of mitochondrial uncoupling proteins—UCPn. Int. J. Biochem. Cell Biol. 2002; 34: 1190 – 1206.
Jianga ZG, Robsonb SC, Yaoc Z. Lipoprotein metabolism in nonalcoholic fatty liver disease. J. Biol. Res. 2013; 27: 1 – 13.
Keller H and Wahli W. Peroxisome proliferator - activated receptors α link between endocrinology and nutrition? Trends. Endocrinol. Metab. 1993; 4: 291 - 296.
Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944 – 2950.
Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ, Kim NG, Koh GY. Molecular cloning, expression, and characterization of angiopoietin-related protein induces endothelial cell sprouting. J. Biol. Chem.1999; 274: 26523 - 26528.
Kim JK, Gimeno RE, Higashimori T. Inactivation of fatty acid transport protein 1 prevents fat - induced insulin resistance in skeletal muscle. J. Clin. Invest. 2004; 113: 756 – 763.
Kim M, Goto T, Yu R, Uchida K, Tominaga M, Kano Y, Takahashil N, Kawada T. Fish oil intake induces UCP1 upregulation in brown and white adipose tissue via the sympathetic nervous system. Nat. Sci. Rep. 2015; 5: 18013.
Kinnunen PK, Ehnolm C. Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase. FEBS Lett. 1976; 65: 354 - 357.
Knutti D and Kralli A. PGC - 1, a versatile coactivator. Trends Endocrinol. Metab. 2001; 8: 360 - 365.
Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li D, Qiu Y, Fraser CC, Yang DD, et al. Transgenic angiopoietin-like (Angptl) 4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride. Metabolism. Endocrinology 2005; 146: 4943 – 4950.
Krauss S, Zhang CY, Lowell BB. The mitochondrial uncoupling-protein homologues. Nat. Rev. Mol. Cell Biol. 2005; 6: 248 – 261..
Lafferty MJ, Bradford KC, Erie DA and Neher SB. Angiopoietin-like protein 4 inhibition of lipoprotein lipase evidence for reversible complex formation. J. Biol. Chem. 2013; 288: 28524 – 28534.
Lage R, Diéguez C, Vidal-Puig A, López M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends. Mol. Med. 2008; 14: 539 – 549.
Lanza IR, Zabielska AB, Johnson ML, Schimke JM, Jakaitis DR, Lebrasseur NK, Jensen MD, Nair KS, Zabielski P. Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2013; 304: 1391 – 1403.
Larsson M, Vorrsjö E, Talmud P, Lookene A and Olivecrona G. apolipoproteins c-i and c-iii inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets. J. Biol. Chem. 2013; 288: 33997 – 34008.
Lazar MA. PPARγ, 10 years later. Biochimie. 2005; 87: 9 – 13.
Lewis GF and Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 2005; 96: 1221 - 1232.
Li C. Genetics and regulation of angiopoietin-like proteins 3 and 4. Curr. Opin. Lipidol. 2006; 17: 152 – 156.
Lin EC, Fernandez ML, McNamara DJ. Dietary fat type and cholesterol quantity interact to affect cholesterol metabolism in guinea pigs. J. Nutr. 1992; 122: 2019 - 2029.
Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN. Transcriptional co-activator PGC-1 drives the formation of slow-twitch muscle fibres. Nature 2002; 418: 797 – 801.
Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N. Ligand selectivity of the peroxisome proliferator-activated receptor α. Biochemistry 1999; 38: 185 – 190.
Liu L and Ouyang D. Function and clinical significance of microsomal triglyceride transfer proteins. Int. J. Clin. Exp. Parho. 2009; 29: 152 – 154.
Liu S, Baracos VE, Quinney HA, Clandinin MT. Dietary omega-3 and polyunsaturated fatty acids modify fatty acyl composition and insulin binding in skeletal-muscle sarcolemma. Biochem. J. 1994; 299: 831 – 837.
Long YC and Zierath R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 2006; 116: 1776 - 1783.
Lopez-Vel´azquez JA, Carrillo-C´ordova LD, Ch´avez-Tapia NC, Uribe M, Mendez-S´anchez N. Review: Nuclear receptors in nonalcoholic fatty liver disease. J. Lipids 2012; 2012: 1-10.
Mendivil CO, Rimm EB, Furtado J, Chiuve SE, Sacks FM. Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. Circulation 2011; 124: 2065 - 2072.
Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler. Thromb. Vasc. Biol. 2010; 30: 239 - 245.
Michael LF, Wu Z, Cheatham RB, Puigserver P, Adelmant G, Lehman JJ, Kelly DP, Spiegelman BM. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. 2001; 98: 3820 – 3825.
Michael WK. (2013) AMPK: Master Metabolic Regulator. Retrieves August 19, 2016 from http://themedicalbiochemistrypage.org/ampk.php
Miles JM, Park YS, Walewicz D, Russell-Lopez C, Windsor S, Isley WL, Coppack SW, Harris WS. Systemic and forearm triglyceride metabolism fate of lipoprotein lipase – generated glycerol and free fatty acids. Diabetes 2004; 53: 521 - 527.
Minokoshi Y, Kim YB, Peroni OD, Fryer LGD, Müller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339 - 343.
Mori TA and Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr. Opin. Clin. Nutr. and Met. Care. 2006; 9: 95 – 104.
Morino K, Petersen KF, Sono S, Choi CS, Samuel VT, Lin A, Gallo A, Zhao H, Kashiwagi A, Goldberg IJ, Wang H, Eckel RH, Maegawa H, Shulman GI. Regulation of mitochondrial biogenesis by lipoprotein lipase in muscle of insulin-resistant offspring of parents with type 2 diabetes. Diabetes 2012; 61: 877 – 887.
Mozaffarian D, Lemaitre RN, King IB, Song XL, Huang H, Sacks FM, Rimm EB, Molin W, Siscovick DS. Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause - Specific Mortality in Older Adults: A Cohort Study. Ann. Intern. Med. 2013; 158: 515 – 525.
Nedergaard J, Ricquier D, Kozak LP. Uncoupling proteins: current status and therapeutic prospects. EMBO 2005; 6: 917 – 921.
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet 2014; 384: 626 - 635.
Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM and Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687 – 698.
Ohira M, Endo K, Saiki A, Miyashita Y, Terai K, Murano T, Watanabe F, Tatsuno I, Shirai K. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase. Metab. 2012; 61: 1452 – 1460.
Ohira M, Miyashita Y, Murano T, Watanabe F, Shirai K. Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metab. 2009; 58: 1408 – 1414.
Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends. Mol. Med. 2005; 11: 473 – 479.
Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y, Koishi R, Furukawa H. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3). J. Biol. Chem. 2003; 278: 41804 – 41809.
Ooi EMM, Barrett PHR, Chan DC, Watts GF. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin. Sci. (Lond) 2008; 114: 611 - 624.
Pan DA, Storlien LH. Dietary lipid profile is a determinant of tissue phospholipid fatty acid composition and rate of weight gain in rats. J. Nutr. 1993; 123: 512 – 519.
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004; 350: 664 – 671.
Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, Tomkin GH. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism 2002 (A); 51: 847 – 852.
Phillips C, Owens D, Collins P, Tomkin GH. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly? Atherosclerosis 2002 (B); 160: 355 – 360.
Pownall HJ, Shepherd J, Mantulin WW, Sklar LA, Gotto JAM. Effect of saturated and polyunsaturated fat diets on the composition and structure of human low density lipoprotein. Atherosclerosis 1980; 36: 299 - 314.
Puigserver P and Spiegelman PM. Peroxisome proliferator-activated receptor - coactivator 1 (PGC-1): Transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003; 24: 78 – 90.
Puigserver P, Adelmant G, Wu Z, Fan M, Xu J, O’Malley B, Spiegelman BM. Activation of PPAR coactivator-1 through transcription factor docking. Sci. 1999; 286: 1368 – 1371.
Puigserver P, Wu Z, Park CW, Graves R. Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92: 829 – 839.
Quintao ECR and Sperotto G. The role of dietary cholesterol in the regulation of human body cholesterol metabolism. Adv. Lipid Res. 1987; 22: 173 – 188.
Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int. J. Obes. (Lond) 2005; 29: 111 – 115.
Rossmeisl M, Jilkova ZM, Kuda O, Jelenik T, Medrikova D, Stankova B, Kristinsson B, Haraldsson GG, Svensen H, Stoknes I, Sjövall P, Magnusson Y, Balvers MGJ, Verhoeckx KCM, Tvrzicka E, Bryhn M, Kopecky J. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. PLOS ONE 2012; 7: 1 - 13.
Rutter GA, Xavier G-daS, Leclerc I. Roles of 5-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 2003; 375:
Sacks FM. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Curr. Opin. Lipidol. 2015; 26: 56 - 63.
Samuels LT, Gilmore LG, Reinecke RM. The effect of previous diet on the ability of animals to do work during subsequent fasting. J. Nutr. 1948; 36: 639 – 647.
Samuels LT, Reinecke RM, Ball HA. Effect of diet on glucose tolerance and liver and muscle glycogen of hypophysectomized and normal rats. Endocrinology 1942; 31: 42 – 53.
Sasaki T, Nakata R, Inoue H, Shimizu M, Inoue J, Sato R. Role of AMPK and PPAR1 in exercise-induced lipoprotein lipase in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2014; 306: 1085 – 1092.
Schrauwen P and Hesselink M. UCP 2 and UCP 3 in muscle controlling body metabolism. J. Exp. Biol. 2002; 205: 2275 – 2285.
Sehayek E and Eisenberg S. Mechanisms of inhibition by apolipoprotein C of apolipoprotein edependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biolo.l Chem. 1991; 266: 18259 – 18267.
Sessions VA, Salter AM. The effects of different dietary fats and cholesterol on serum lipoprotein concentrations in hamsters. Biochim. Biophys. Acta. 1994; 1211: 207 – 214.
Sethi JK, and Hotamisligil G. The role of TNF-α in adipocyte metabolism. Cell. Dev. Biol, 1999; 10: 19 – 29.
Shearera GC, Savinovaa OV, Harrisb WS. Fish oil-how does it reduce plasma triglycerides? Biochim. Biophys. Acta. 2012; 1821: 843 – 885.
Shepherd J, Packard CJ, Grundy SM, Yeshurun D, Jr AMG and Taunton OD. Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J. Lipid Res. 1980; 21: 91 – 99.
Simoneau JA and Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 1997; 83: 166 – 171.
Singh I. Biochemistry of peroxisomes in health and disease. Mol. Cell. Biochem. 1997; 167: 1 - 29.
Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am. J. Clin. Nutr. 2011; 93: 243 - 252.
Sparks JD and Sparks.CE. Overindulgence and metabolic syndrome: is FOXO1 a missing link? J. Clin. Invest. 2008; 118: 2012 – 2015.
Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005; 54: 1926 – 1933.
Stitziel NO, Stirrups KE, Masca NGD, Erdmann J, Ferrario PG, König IR, Weeke P E, et al. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 2016; 374: 1134 - 1144.
Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and ω - 3 fatty acids in muscle phospholipid. Diabetes 1991; 40: 280 – 289.
Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885 – 888.
Sukonina V, Lookene A, Olivecrona T, Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. PNAS 2006; 103: 17450 – 17455.
Towler MC and Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Am. Heart Assoc. Circ. Res. 2007; 100: 328 – 341.
Tsukamoto K, Maugeais C, Glick JM, Rader DJ. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice. J. Lipid Res. 2000; 41: 253 - 259.
Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol. Ther. 2014; 141: 358 - 367.
Wahli W, Braissant O, Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 1995; 2: 261 - 266.
Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. effect of apolipoprotein C-l1l. J. Clin. Invest. 1985; 75: 384 – 390.
Wang H, Chen X, Fisher EA. n-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J. Clin. Invest. 1993; 91: 1380 – 1389.
Wang H, Knaub LA, Jensen DR, Young JD, Hong EG, Ko HJ, Coates AM, Goldberg IJ, Houssaye BA, Janssen RC, McCurdy CE, Rahman SM, Soo CC, Shulman GI, Kim JK, Friedman JE, Eckel RH. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 2009; 58: 116 – 124.
Wang YR, McLeod S, Yao ZM. Normal activity of microsomal triglyceride protein is required for the oleate-induced secretion of very low density lipoproteins containing apoprotein B from McA-RH7777 cells. J. Biol. Chem. 1997; 272: 12272 – 12278.
Wetterau JR, Gregg RE, Harrity TW, Arbeeny C, Cap M, Connolly F, Chu C, George RJ, Gordon DA, Jamil H, Jolibois KG, Kunselman LK, Lan S, Maccagnan TJ, Ricci B, Yan M, Young D, Chen Y, Fryszman OM, Logan JVH, Musial CL, Poss MA, Robl JA, Simpkins LM, Slusarchyk WA, Sulsky R, Taunk P, Magnin DR, Tino JA, Lawrence RM, Dickson JK, Biller SA. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 1998; 282: 751 – 754.
White DA, Bennett AJ, Billett MA, Salter AM. The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triglyceride transfer protein. Br. J. Nutr. 1998; 80: 219 – 229.
Wickelgren I. Obesity: How Big a Problem? Sci. 1998; 280: 1364 – 1367.
Yu X, Burgess SC, Ge H, Wong KK, Nassem RH, Garry DJ, Sherry AD, Malloy CR, Berger JP, Li C. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc. Natl. Acad. Sci. 2005; 102: 1767 – 1772.
Zheng C, Khoo C, Furtado J, Sacks FM. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 2010; 121: 1722 - 1734.
Ziccardi P, Nappo F, Giugliano Gi, Esposito K, Marfella R, Cioffi M, D’Andrea F, Molinari AM, Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804 - 809.
Zierath JR, Houseknecht KL, Gnudi L, Kahn BB. High fat feeding impairs insulin - stimulated Glut4 recruitment via an early insulin-signaling defect. Diabetes 1997; 46: 215 – 223.